語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Uncertainty in pharmacologyepistemol...
~
LaCaze, Adam.
Uncertainty in pharmacologyepistemology, methods, and decisions /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Uncertainty in pharmacologyedited by Adam LaCaze, Barbara Osimani.
其他題名:
epistemology, methods, and decisions /
其他作者:
LaCaze, Adam.
出版者:
Cham :Springer International Publishing :2020.
面頁冊數:
xiii, 470 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
標題:
Pharmacology.
電子資源:
https://doi.org/10.1007/978-3-030-29179-2
ISBN:
9783030291792$q(electronic bk.)
Uncertainty in pharmacologyepistemology, methods, and decisions /
Uncertainty in pharmacology
epistemology, methods, and decisions /[electronic resource] :edited by Adam LaCaze, Barbara Osimani. - Cham :Springer International Publishing :2020. - xiii, 470 p. :ill., digital ;24 cm. - Boston studies in the philosophy and history of science,v.3380068-0346 ;. - Boston studies in the philosophy and history of science ;v.295..
Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. "Caught in the Amber": a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer's Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of "the Blind Test" of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism-The Case of Flibanserin.
This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result-which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries.
ISBN: 9783030291792$q(electronic bk.)
Standard No.: 10.1007/978-3-030-29179-2doiSubjects--Topical Terms:
218135
Pharmacology.
LC Class. No.: RM301 / .U53 2020
Dewey Class. No.: 615
Uncertainty in pharmacologyepistemology, methods, and decisions /
LDR
:04056nmm a2200337 a 4500
001
575306
003
DE-He213
005
20200220152055.0
006
m d
007
cr nn 008maaau
008
201016s2020 sz s 0 eng d
020
$a
9783030291792$q(electronic bk.)
020
$a
9783030291785$q(paper)
024
7
$a
10.1007/978-3-030-29179-2
$2
doi
035
$a
978-3-030-29179-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RM301
$b
.U53 2020
072
7
$a
HP
$2
bicssc
072
7
$a
MED050000
$2
bisacsh
072
7
$a
QD
$2
thema
082
0 4
$a
615
$2
23
090
$a
RM301
$b
.U54 2020
245
0 0
$a
Uncertainty in pharmacology
$h
[electronic resource] :
$b
epistemology, methods, and decisions /
$c
edited by Adam LaCaze, Barbara Osimani.
260
$a
Cham :
$c
2020.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
xiii, 470 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Boston studies in the philosophy and history of science,
$x
0068-0346 ;
$v
v.338
505
0
$a
Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. "Caught in the Amber": a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer's Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of "the Blind Test" of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism-The Case of Flibanserin.
520
$a
This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result-which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries.
650
0
$a
Pharmacology.
$3
218135
650
1 4
$a
Philosophy of Medicine.
$3
275170
650
2 4
$a
Theory of Medicine/Bioethics.
$3
275636
700
1
$a
LaCaze, Adam.
$3
863190
700
1
$a
Osimani, Barbara.
$3
863191
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
830
0
$a
Boston studies in the philosophy and history of science ;
$v
v.295.
$3
569079
856
4 0
$u
https://doi.org/10.1007/978-3-030-29179-2
950
$a
Religion and Philosophy (Springer-41175)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000181413
電子館藏
1圖書
電子書
EB RM301 .U54 2020 2020
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
https://doi.org/10.1007/978-3-030-29179-2
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入